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Introduction. Stroke survivors use more energy than healthy people during activities such as walking, which has consequences
for the way exercise is prescribed for stroke survivors. There is a need for wearable device that can validly measure energy
expenditure (EE) of activity to inform exercise prescription early after stroke. We aimed to determine the validity and reliability of
the SenseWear-Armband (SWA) to measure EE and step-counts during activity <1 month after stroke.Materials and Methods. EE
was measured using the SWA andmetabolic cart and steps-counts were measured using the SWA and direct observation. Based on
walking ability, participants performed 2x six-minute walks or repeated sit-to-stands. Concurrent validity and test-retest reliability
were determined by calculating intraclass and concordance correlation coefficients. Results and Discussion. Thirteen participants
walked; nine performed sit-to-stands. Validity of the SWAmeasuring EE for both activities was poor (ICC/CCC < 0.40). The SWA
overestimates EE during walking and underestimated EE during sit-to-stands. Test-retest agreement showed an ICC/CCC of <0.40
and >0.75 for walking and sit-to-stand, respectively. However, agreement levels changed with increasing EE levels (i.e., proportional
bias).The SWAdid not accuratelymeasure step-counts.Conclusion.TheSWA should be used with caution tomeasure EE of activity
of mild to moderate stroke survivors <1 month after stroke.
1. Introduction
Cardiorespiratory fitness levels are low early after stroke
(i.e., <1 month since stroke onset), with fitness levels of
stroke survivors ranging from 44% to 76% that of age-
and sex-matched sedentary healthy adults [1–3]. In stroke
survivors, exercising at a moderate intensity, progressing
to high intensity can elicit a cardiorespiratory training
effect leading to improved cardiorespiratory fitness [4]. Our
recent systematic review results showed that walking is more
effortful for stroke survivors compared to healthy controls
based on energy expenditure (EE) levels; and in some stroke
survivors slow walking equals moderate intensity activity [5],
which could lead to improvements in cardiovascular fitness.
Understanding the EE of activities can inform development
of exercise interventions in stroke survivors.
Indirect calorimetry using a metabolic cart is commonly
used to measure the EE of physical activities. The metabolic
cart measures the volume of oxygen uptake (VO2) using
breath-by-breath analyses and has been shown to be a
valid measure of VO2 uptake during different workloads in
sedentary adults,moderately trained individuals, and athletes
[6].The development of mobile metabolic carts has extended
the measurement from stationary activities (e.g., cycling on
an ergometer or walking on a treadmill) to unfixed activities
(e.g., overground walking). This more flexible method, while
considered “gold standard,” remains cumbersome and costly
and needs a trained staffmember to operate themachine. It is
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not readily usable in an acute clinical stroke setting. Sensor-
based technology, including wearable devices, may be a low-
cost, noninvasive, and broadly applicable tool to measure the
EE of physical activity in the clinic early after stroke, provided
it is valid and reliable.
In a recent systematic review 60 different devices to
measure physical activity in stroke were identified [7]. Of
these devices, three had the potential tomeasure EE: theActi-
cal (Koninklijke Philips NV), Body fixed sensor (Physilog,
BioAGM), and the SenseWear Pro3 (Bodymedia Inc). The
SenseWear (SWA) is worn on the upper arm and is the
only multisensor device that includes accelerometer data as
well as near body temperature, heat flux, and galvanic skin
responses.Moore et al. showed that the SWAmeasure of daily
EE, when worn on the unaffected arm (SWAunaffected), was
highly correlated with doubly labelled water (gold standard)
in chronic stroke survivors (2473 ± 468 versus 2380 ±
551 kcal/day, resp.) [8]. EE during walking measured by
the SWAunaffected showed good agreement (ICC > 0.70) and
the SWAaffected showed fair agreement (ICC < 0.60) with a
metabolic cart in chronic stroke survivors, suggesting that
the SWA worn on the unaffected arm gives a more accurate
estimate of EE during walking [9]. In the same study, the
authors reported that the SWA step-count measures appear
to be less promising [9]. It is unclear whether the easy-to-
apply SWAdevice is a reliable and validmarker of EE in those
with acute stroke. We wanted to determine the validity and
reliability of the SWAunaffected to measure EE during activity
in peoplewith acute stroke, that is, within the firstmonth after
stroke.
This study is a part of a larger study in which we aimed
to compare EE of acute stroke survivors to healthy controls.
In this paper we will only discuss the result regarding the
validity and reliability of the SWAunaffected. Using a mobile
metabolic cart as a gold standard we sought to determine the
concurrent validity and reliability of SWA measures of EE
during a physical activity in stroke survivors whose stroke
onset was less than 1 month ago. We hypothesised that the
SWAunaffected is a valid and reliable tool to estimate EE during
activity in acute stroke survivors.
2. Material and Methods
2.1. Participants. Stroke survivors admitted to the acute
stroke ward at the Austin Hospital in Melbourne, Australia,
were eligible to participate if they met the following criteria:
(1) >18 years of age, (2) being within 1 month after stroke,
(3) clinically diagnosed with stroke, (4) cognitively able to
consent as assessed by the treating clinician, (5) sufficient
English language command to follow complex instructions,
and (6) medically cleared to participate by their treating
clinician.
Stroke survivors were excluded from participating in the
study if they had (1) comorbidities that impaired their ability
to either walk or perform sit-to-stands (i.e., repeated standing
up from and sitting down on a plinth) for six minutes (e.g.,
severe Chronic Obstructive Pulmonary Disorder, lower limb
surgery) or (2) other neurological comorbidities that might
affect the EE of activity (e.g., Parkinson’s disease).
All stroke survivors who participated in this study pro-
vided written informed consent. The study was approved
by the Austin Health Human Research Ethics Committee
(reference number H2011/04447).
2.2. Assessment and Measurement. Each participant’s age,
height (measured using a stadiometer), weight while clothed
but without shoes (measured using digital scales), and
smoking status were recorded. Additionally, we obtained
date of stroke, severity of stroke on admission, and stroke
subtype from the participant’s medical records. The National
Institutes of Health Stroke Severity (NIHSS) scale was used
to measure stroke severity with scores ranging from 0 to
42. Stroke severity was categorised into mild (<8), moderate
(8–16), and severe (>16) [10].
2.3. Procedure. Tomeasure EE of activity in both ambulatory
and nonambulatory stroke survivors, we used two different
test protocols: walking and sit-to-stand. Stroke survivors able
to ambulate under supervision or with light manual support
for balance and coordination (with or without a walking aid)
performed the walking protocol. Stroke survivors who were
unable to walk independently and needed manual support
from at least two people performed the sit-to-stand protocol.
We consulted with the participants’ treating clinician (i.e.,
neurologist or allied health professional) to determine which
protocol was most appropriate. All participants started with a
three-minute resting period in a seated position followed by
two bouts of six minutes of continuous activity (i.e., walking
or sit-to-stands). Between the two bouts, participants rested
for 30minutes in different positions (i.e., seated, lying flat, and
lying on an incline), allowing EE to return to baseline levels
before commencing the second six-minute bout. We aimed
for participants to reach steady-state during the six-minute
activity bouts, with steady-state defined as variability in VO2
of less than 2.0mLO2/kg/min over the last three minutes of
activity [11].
Ambulatory stroke survivors walked back and forth along
a 30-metre corridor at a self-selected pace. Participants per-
forming the sit-to-stand protocol started in a seated position
on a height-adjustable physiotherapy plinth, which was set at
a height that requiredmoderate effort andminimal assistance
only for balance from the researchers. Before every test we
emphasised to the participant that the goal was to move at a
steady pace and not to move as fast as possible during the six
minutes of activity.
EE was measured using a metabolic cart (Oxycon
Mobile Device, CareFusion Australia Pty Ltd) and the SWA.
For completeness, we applied one SWA on each arm (the
armmost impaired from the stroke—affected—and the other
arm—unaffected). We only reported and discussed data
regarding the SWAunaffected; the data of the SWAaffected can be
found in the supplementary materials.
The SWAs were placed dorsal on the upper limb midway
between the elbow and shoulder joint. The SWA consists
of triaxial accelerometers that record movement and posi-
tion, and sensors that measure heat flux and galvanic skin
response. Data from the accelerometers and sensors are
integrated and converted to EE in Metabolic Equivalent of
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Tasks (METs) per minute using proprietary algorithms of the
manufacturer.
The metabolic cart measured VO2 continuously using
breath-by-breath analyses, averaged over three breaths; the
readout of the data was in five-second epochs. Calibra-
tion of the metabolic cart was performed according to the
manufacturer’s operational instructions prior to testing. Gas
calibration was performed against gas with a ratio of 16%
O2 and 4% CO2 in Nitrogen. The ambient conditions were
automatically measured by the unit. The participants were
fitted with a facemask and a harness that carries the Oxycon
units that allow telemetric transmission of data to a laptop.
Step-count was recorded by direct observation using a
manual counter and by the SWA. The accelerometer output
of the SWA is converted to step-counts using proprietary
algorithms of themanufacturer. Sit-to-stand counts were also
recorded by direct observation using a manual counter; a
single sit-to-stand was counted when the participant stood
up and sat back down.
The test protocol was terminated if a participant did
not meet the following criteria assessed in a sitting position
before the six-minute activity bouts: systolic blood pressure
between 120 to 220mmHg (automatic blood pressure moni-
tor OMRON, Australia), oxygen saturation > 92%, heart rate
between 40 and 100 bpm (pulse oximeter, Oxycon Mobile
Device, CareFusion Australia Pty Ltd), and temperature
< 38.5∘C (tympanic thermometer, Covidien, Medtronics,
Australia). The test was also terminated if the participant
requested stopping or felt unwell.
Purposeful sampling was used to recruit participants and
we aimed to include stroke survivors who were able and not
able to walk.We considered it feasible and practical to recruit
20 stroke survivors.We continued recruitment until 20 stroke
survivors completed both activity bouts and had complete
data sets including EE data measured by the metabolic cart
and SWAunaffected.
2.4. Data Processing and Analysis. After the test had been
completed the data of the metabolic cart and SWAs were
downloaded on to a computer. In this study we expressed
EE in METs. The Oxycon expresses EE in VO2 in ml/kg/min
which is automatically converted toMETs/min, where 1MET
is equal to a VO2 of 3.5ml/kg/min.
The output of the metabolic cart data is averaged over
five-second epochs; we averaged the metabolic cart data for
each minute to match the SWA data, which is collected in
METs/min. EE under steady-state conditions was calculated
by averaging the EE output over the last three minutes of
the six-minute bouts for each participant for both the data
acquired by the metabolic cart and the SWAs. We used
descriptive statistics, calculated medians and interquartile
ranges (IQR) for demographic data, anthropometric data,
walking speed, step-counts, and sit-to-stand counts, and we
calculated means and standard deviations for the EE of
steady-state activity.
We confirmed that all EE data were normally distributed
using the Shapiro-Wilk test. We calculated intraclass corre-
lation coefficients (ICC) and Lin’s concordance correlation
coefficients (CCC) to assess agreement between measures.
Both ICC [12] and CCC [13] are valid statistics to determine
agreement between measures.
Additionally we employed reduced major axis (RMA)
regression, which is appropriate in the setting of this study,
where both measurement tools produce readings that are
susceptible to measurement error [14]. The regression anal-
ysis yields slope and intercept. A slope different from 1 is
indicative of proportional bias. If the slope is 1 or close
to 1 then the intercept needs to be interpreted, where an
intercept different from 0 is indicative of fixed bias. The
two components provide readings that differ by a consistent
amount across magnitude (fixed bias) or that differ by a
changing amount across magnitude (proportional bias) [15,
16]. We generated scatterplots including the line of perfect
concordance and the RMA.
2.5. Outcomes
2.5.1. Primary Outcome: Energy Expenditure. To test our
hypotheses regarding concurrent validity of the SWAunaffected,
we determined agreement between themetabolic cart and the
SWAunaffected for the followingmeasures: (1) EEof steady-state
walking and (2) EE of steady-state sit-to-stand. Test-retest
reliability for both the metabolic cart and the SWAunaffected
was assessed by determining agreement between EE mea-
surements taken during the 1st and 2nd bout during walking
and sit-to-stand.
2.5.2. SecondaryOutcome: Step-Counts duringWalking. Step-
count measurements of the SWA utilise accelerometer data
from the movement of the wearer’s arm. When the wearer’s
arms are fixed on walking frames or supported by people
walking with physical assistance, the recorded accelerometry
data are likely to lack validity. We therefore excluded step-
count data of participants who walked with a 4-wheel frame
or required physical assistance. We tested our hypothesis
regarding concurrent validity of the SWA by determining
agreement between the observed step-counts and step-counts
recorded by the SWAunaffected. Test-retest reliability of the
SWAswas determined by agreement between the step-counts
recorded during the 1st and 2nd bout of walking.
We used the following ICC and CCC cutoff points to
interpret the strength of agreement: less than 0.40: poor,
between 0.40 and 0.59: fair, between 0.60 and 0.74: good,
and between 0.75 and 1.00: excellent [17]. All analyses were
performed using Stata 13 (StataCorp LP).
3. Results
We recruited 23 acute stroke survivors. Fourteen participants
completed the walking protocol; one participant was unable
to complete the second bout of walking due to fatigue. We
excluded the data of another participant who completed less
than 2.5 minutes of walking due to fatigue. Nine participants
performed the sit-to-stand protocol; we had missing data for
two participants due to machine failure and one participant
was unable to perform the second bout of sit-to-stands
due to fatigue. One participant had a bilateral stroke and
performed the sit-to-stand protocol. The SWA data of both
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Recruited 23
participants
Walking protocol 
n = 14 
Excluded n = 1
unable to complete 6 min of 
walking
Missing data n = 1
2nd walk not performed due
to metabolic cart failure
1st walk:
Metabolic cart data n = 13
SW affected n = 13
SW unaffected n = 13
2nd walk: 
Metabolic cart n = 12
SW affected n = 12
SW unaffected n = 12
Sit-to-stand
protocol
n = 9
Excluded n = 0
Missing data n = 2
2 metabolic cart failure
1 only completed 1st bout
due to fatigue
1st STS:
Metabolic cart data n = 7
SW affected n = 9
SW unaffected n = 8
2nd STS:
Metabolic cart n = 6
SW affected n = 8
SW unaffected n = 7
Figure 1: Flowchart of datasets for metabolic cart and SWA available for analyses.
Table 1: Participant characteristics.
All
(𝑛 = 22)
Walking
(𝑛 = 13)
Sit-to-stand
(𝑛 = 9)
Age, years 78 (70 to 83) 78 (70 to 85) 78 (73 to 78)
Male (𝑛) 13 9 4
Time since stroke, days 4 (2 to 6) 4 (2 to 6) 4 (3 to 5)
Height, cm 164.5(159.0 to 173.0)
163.0
(161.8 to 171.0)
165.0
(159.0 to 173.0)
Body weight, kg 73.0(62 to 90)
72.2
(61.1 to 81.3)
76.7
(72.2 to 90.0)
Affected side, 𝑛 = right/ bilateral 8/1 5/0 3/1
Stroke severity:
Mild NIHSS < 8 (𝑛) 18 11 7
Moderate NIHSS 8–16 (𝑛) 4 2 2
Severe NIHSS > 16 (𝑛) 0 0 0
All data is reported as medians and IQRs unless stated otherwise.
arms of this participant were regarded as EE of the affected
arm (SWAaffected). We included the average of EE values of
both arms for this participant in the analyses; hence the
difference in numbers of SWA measures in the group that
performed sit-to-stand (Figure 1).TheEE and step-count data
of the SWAaffected compared to the metabolic cart and direct
observations can be found in the supplement.
We analysed the data of 22 participants. The median age
was 78 (IQR 73–81) and all participants performed the test
within the first seven days after stroke (Table 1), except for
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Table 2: Energy expenditure of walking and sit-to-stands and agreement between the metabolic cart and SWAunaffected.
Outcome energy expenditure (METs)
Activity bout (𝑛) Metabolic cart SWAunaffected
Mean difference
(SD) ICC (95% CI)
CCC (𝑟𝑐) (95%
CI) RMA slope RMA intercept
1st walk
(𝑛 = 13) 2.72 (0.54) 3.65 (0.76) −0.93 (0.66) 0.02 (0.0 to 0.54)
0.24 (−0.02 to
0.51) 1.42 −0.21
2nd walk
(𝑛 = 12) 2.78 (0.52) 3.47 (0.49) −0.69 (0.45) 0.13 (0.0 to 0.63)
0.31 (0.02 to
0.61)∗ 0.94 0.85
1st sit-to-stands
(𝑛 = 6) 2.35 (0.95) 2.21 (0.94) 0.47 (0.79) 0.38 (0.0 to 0.88)
0.37 (−0.33 to
1.00) 1.04 −0.57
2nd sit-to-stands
(𝑛 = 5) 2.49 (1.07) 1.83 (1.22) 1.08 (0.85) 0.25 (0.0 to 0.88)
0.34 (−0.19 to
0.86) 0.64 −0.14
Energy expenditure is reported as mean (SD); ∗𝑝 = 0.03; ICC: intraclass correlation coefficient; CCC: concordance correlation coefficient; RMA: reduced
major axis.
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(b) Energy expenditure walking (2nd): metabolic cart and SWAunaffected
Figure 2
one participant who was tested at 13 days after stroke. The
median walking speed was 0.59m/sec (IQR 0.54 to 0.72) and
0.60m/sec (IQR 0.47 to 0.92) during the 1st and 2nd bout,
respectively. Participants who performed both bouts of sit-
to-stands were able to complete a median of 93 sit-to-stands
(IQR 40 to 113) during the 1st bout (𝑛 = 7) and a marked
higher median of 94 (IQR 40 to 121) during the 2nd bout
(𝑛 = 7).
3.1. Concurrent Validity: EE Measured by Metabolic
Cart and SWA𝑢𝑛𝑎𝑓𝑓𝑒𝑐𝑡𝑒𝑑
3.1.1. Walking. During both the 1st and 2nd bouts of walking
we found poor agreement (ICC/CCC < 0.40) between EE
measured by the metabolic cart and the SWAunaffected. There
was evidence of proportional bias (slope = 1.42) during the
1st bout with agreement decreasing at higher levels of EE
(Table 2 and Figure 2(a)), whereas the slope during the 2nd
bout was 0.94; the SWAunaffected systematically overestimated
EE (Table 2 and Figure 2(b)).
3.1.2. Sit-to-Stands. We found poor agreement (ICC/CCC
< 0.40) between the EE of sit-to-stands measured by the
metabolic cart and the SWAunaffected for both sit-to-stand
bouts. During the 1st bout of sit-to-stands, there was lit-
tle evidence for proportional bias; the SWA systematically
underestimated EE (intercept = −0.57). During the 2nd bout
there was some evidence of proportional bias (slope = 0.64)
where agreement decreased at higher EE levels (see Table 2).
3.2. Test-Retest Reliability: EE during Walking. We first
assessed the test-retest reliability of our gold standard, the
metabolic cart, and found excellent agreement between the
EE measured during the 1st and the 2nd bout of walking
(ICC = 0.96, 95% CI 0.87 to 0.99; CCC = 0.96, 95% CI 0.90
to 1.00, 𝑛 = 12). There was no evidence of proportional or
fixed bias (slope = 1.05 and intercept = −0.19) indicating that
participants performed at a similar level across bouts.
However, this was not the case for EE of walking mea-
sured using the SWAunaffected, which showed poor agreement
between the two time points (ICC = 0.39, 95% CI 0.0 to 0.77;
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Table 3: Step-counts and agreement between observed count and SWAunaffected.
Outcome step-counts
Activity bout (𝑛) Observedcounts SWAunaffected
Mean difference
(SD) ICC (95% CI) CCC (95% CI) RMA slope RMA intercept
1st walk (𝑛 = 8) 592 (87) 356 (219) −235 (173) 0.0 (0.0 to 0.66) 0.22 (−0.04 to0.48) 2.52 −1133
2nd walk (𝑛 = 8) 602 (87) 411 (207) −191 (150) 0.16 (0.0 to 0.74) 0.30 (0.01 to0.59)∗ 2.39 −1026
All data is reported as mean (SD) unless stated otherwise; ∗𝑝 = 0.03; ICC: intraclass correlation coefficient; CCC: concordance correlation coefficient; RMA:
reduced major axis.
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Figure 3: SWAunaffected: energy expenditure between 1st and 2nd
bout of walking.
CCC = 0.37, 95% CI −0.08 to 0.82, 𝑛 = 12).The RMA showed
proportional bias (slope = 0.63 and intercept = 1.15) indicating
that when EE levels increase just beyond 3 METs, agreement
gets poorer (Figure 3).
3.3. Test-Retest Reliability: EE during Sit-to-Stands. The
metabolic cart was reliable between bouts of sit-to-stands,
similar to our finding for walking, with excellent agreement
of EE measures between the 1st and 2nd bout of sit-to-
stands (ICC = 0.93, 95% CI 0.64 to 0.99; CCC = 0.92,
95% CI 0.82 to 1.0, 𝑛 = 6); however, there was some
evidence of proportional bias (slope = 0.74 and intercept =
0.53) with agreement reducing at higher levels of EE. In the
scatterplot (not shown) we identified one clear outlier. This
individual moved substantially faster during the second bout
compared to the 1st bout, completing 139 sit-to-stands versus
116, respectively. Post hoc analysis of the data excluding the
outlier resulted in an ICC of 0.99 (95% CI 0.93 to 1.00) and
a CCC of 0.99 (95% CI 0.96 to 1.0; 𝑛 = 5) and a slope and
intercept of 1.12 and −0.25, respectively, indicating that the
remaining participants performed at a similar rate between
bouts.
Agreement was excellent for EE measures between the 1st
and 2nd bout of sit-to-stands recorded by the SWAunaffected
(ICC = 0.90, 95% CI 0.58 to 0.98; CCC = 0.89, 95% CI 0.74 to
1.0, 𝑛 = 7). The RMA showed proportional bias (slope = 0.80
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Figure 4: Energy expenditure SWAunaffected: 1st and 2nd bout of sit-
to-stands.
and intercept = 0.65) with agreement improving up to an EE
level of 3.5 (Figure 4).
3.4. Concurrent Validity: Step-Counts Measured by Observed
Step-Counts and SWA𝑢𝑛𝑎𝑓𝑓𝑒𝑐𝑡𝑒𝑑. We excluded step-count data
of five participants who walked with a walking frame or
needed physical assistance; the analyses included data of 8
participants. The average number of step-counts measured
by the SWAunaffected was substantially lower (>190 steps)
than the average step-counts measured via direct observation
(Table 3).
The SWAunaffected showed poor agreement with observed
step-counts during the 1st bout and 2nd bout of walking and
the RMA slopes were large showing evidence of proportional
bias with agreement improving when step-counts increase
(Table 3).
4. Discussion
We set out to determine if the SWA wearable device could
provide a valid measure of EE during physical activity in
acute stroke patients. Our results indicated that the SWA
worn on the unaffected arm did not accurately measure
EE during a bout of physical activity; rather, it seemed
to overestimate EE compared to the metabolic cart during
walking and underestimate EE during sit-to-stands. Our
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findings regarding EE during walking are in contrast with
the findings in the Manns and Haennel (2012) study. Their
study, which included 12 chronic stroke survivors, found
good agreement (ICC = 0.70) between EE measured by the
metabolic cart and the SWA during a six-minute walk [9].
In our study agreement was poor (CCC < 0.40). It has been
suggested that slower walking speeds might lead to decreased
accuracy of EE estimation by the SWA [9]. Our results do
not support this suggestion, since the participants in our
study walked at a higher average speed and used less energy
compared to the participants in the Manns and Haennel
study.The SWAuses an algorithm that integrates information
collected from the triaxial accelerometer and the sensors that
detect heat flux, temperature, and galvanic skin reaction, to
estimate EE. There are no details available regarding this
algorithm, preventing us from exploring which factors might
have influenced the accuracy of EE estimates.
We found that the SWA greatly underestimated step-
counts by approximately 300 steps on average within two
weeks of stroke onset. This difference was larger than the
difference found in the Manns and Haennel study in which
step-counts measured by the SWA were compared to step-
counts measured by the StepWatch Activity Monitor (SAM)
in stroke survivors > 6 months after stroke [9]. The SAM is
a highly accurate device to measure step-counts [18] and it is
therefore unlikely that the use of a different criterion could
be an explanation for the difference in agreement between
our studies. Recall that step-counts recorded by the SWA are
mostly derived from the accelerometer datawhich is based on
arm swing. Tominimise the impact of reduced arm swing, we
purposefully only reported data from the SWAunaffected and
excluded data from participants that walked with physical
assistance or with a walking aid from the step-count analyses.
It is possible, though, that the included participants also had
lower-than-normal arm swing during walking. The results of
our study confirm that the SWA is not a valid tool to measure
step-counts in stroke survivors. A recent review highlights
that there are other accelerometer based tools available that
validly and reliably measure step-counts [7].
It is however important that our results are interpreted
with caution; no formal calculations were performed to
predetermine sample size and the sample size of this study
was small. On the other hand we did compare the data
of the SWA to the metabolic cart, which is regarded as
a gold standard, and showed that in our sample it was
a reliable measure of EE of activity and we are confident
that the metabolic cart is a true measure of EE. Including
a broad variety of stroke survivors in a clinical study like
this is challenging. We were able to include ambulatory and
nonambulatory stroke survivors within 14 days of stroke
onset. Almost all of our participants, except one, were able
to reach steady-state (22/23), regardless of their ability to
ambulate. Exercising under steady-state conditions is one
of the methods to improve cardiorespiratory fitness and we
showed that some stroke survivors have the potential to start
performing cardiorespiratory exercise early after stroke. It is
important, however, that all of the included stroke survivors
had mild to moderate stroke severity.
The differences between SWA and metabolic cart were
systematic and small. During walking, EE was overesti-
mated by less than 1.0MET and during sit-to-stands it was
underestimated by less than 1.1METs. Considering that the
range of activity intensity is 3METs, that is, light intensity
is <3METs and moderate intensity is 3–6METs, a difference
of less than 1.1METs is relatively small. It is a concern,
however, that the direction of the estimation error was not
consistent across the two activities we tested.Therapy session
in stroke rehabilitation can consist of different exercises
including walking and sit-to-stand amongst other activities.
Furthermore the test-retest reliability of the SWAunaffected
measuring EE showed mixed results regarding agreement,
but most importantly the RMAs for both walking and sit-
to-stands showed that agreement changed when levels of EE
change. This suggests that SWA EE output during therapy
sessions with mixed activities would be highly variable, and
using the SWA would not be a reliable method to track EE
over time.
5. Conclusion
Based on the results of our study the SWAdoes not accurately
measure EE and therefore should be used with caution when
measuring EE during activities early after stroke.
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